![Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - ScienceDirect Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673622000125-gr2.gif)
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - ScienceDirect
![Discount POC Urbane Cap - 1002 Uranium Black new collection sale | Quality Guarantee 100% at poccycling.com Discount POC Urbane Cap - 1002 Uranium Black new collection sale | Quality Guarantee 100% at poccycling.com](https://www.poccycling.com/wp-content/uploads/2022/06/poc-urbane-cap-1002-uranium-black-2-1064561.jpg)
Discount POC Urbane Cap - 1002 Uranium Black new collection sale | Quality Guarantee 100% at poccycling.com
![Fuel Offroad Matte Black Center Cap CAP 1002-48BR CAP M-854BK04 904-14 1001-63-B – The Center Cap Store Fuel Offroad Matte Black Center Cap CAP 1002-48BR CAP M-854BK04 904-14 1001-63-B – The Center Cap Store](https://cdn.shopify.com/s/files/1/1161/1172/products/fuel-offroad-matte-black-center-cap-cap-1002-48br-cap-m-854bk04-904-14-1001-63-b-276122_1024x1024.jpg?v=1561489689)
Fuel Offroad Matte Black Center Cap CAP 1002-48BR CAP M-854BK04 904-14 1001-63-B – The Center Cap Store
![The Lancet Publishes Positive Results from Capricor's Phase 2 Study of CAP- 1002 in Late-Stage Duchenne - Parent Project Muscular Dystrophy The Lancet Publishes Positive Results from Capricor's Phase 2 Study of CAP- 1002 in Late-Stage Duchenne - Parent Project Muscular Dystrophy](https://www.parentprojectmd.org/wp-content/uploads/2021/09/capricor-blog.png)
The Lancet Publishes Positive Results from Capricor's Phase 2 Study of CAP- 1002 in Late-Stage Duchenne - Parent Project Muscular Dystrophy
![Capricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD) • BioTech Health X Capricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD) • BioTech Health X](https://biotechhealthx.com/wp-content/uploads/2021/09/Capricor-Therapeutics-To-Present-Final-HOPE-2-Trial-CAP-1002-Data-for-Late-Stage-Duchenne-Muscular-Dystrophy-DMD-1160x627.jpg)
Capricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD) • BioTech Health X
![Capricor Announces Initiation of HOPE-2 Clinical Trial Of CAP-1002 for Duchenne Muscular Dystrophy - Action Duchenne Capricor Announces Initiation of HOPE-2 Clinical Trial Of CAP-1002 for Duchenne Muscular Dystrophy - Action Duchenne](https://www.actionduchenne.org/wp-content/uploads/2019/04/getimage-17.png)